AzTrials
AzTrials

Diagnosis-Related GroupsNCT04726202

Impact of Semi-automated Proposal and Optimization of Diagnoses and Surgical Procedures for Precoding: a Randomized Controlled Trial

An observational study of Diagnosis-Related Groups and Healthcare Common Procedure Coding System, run by Thomas Steffen at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The hypothesis of present study is that the daily monitoring and optimization of DRG coding is associated with higher reimbursement. Therefore, the primary objective is to determine if the daily monitoring and optimization of DRG coding of individual cases leads to better proceeds per day. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Standard procedure and precoding
How many people
1,200 participants
Where
1 siteSwitzerland
Study dates
1 Jun 2019to 31 Jan 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: patients undergoing inpatient surgery in the fields of General, Visceral, Endocrine or Transplantation Surgery

Who may be able to join

  • patients undergoing surgery as inpatients (at least one night stay)
  • treated at the Kantonsspital St. Gallen, St. Gallen site

Who cannot join

  • surgery as outpatients
  • surgery at the Rorschach and Flawil sites
  • patients operated on by the Department of Surgery, but hospitalized at another department of the hospital

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Department of Surgery, Cantonal Hospital of St. Gallen

    Sankt Gallen, 9007

Other trials in Switzerland

About this study

The hypothesis of present study is that the daily monitoring and optimization of DRG coding is associated with higher reimbursement. Therefore, the primary objective is to determine if the daily monitoring and optimization of DRG coding of individual cases leads to better proceeds per day.

Being tested
Standard procedure, precoding
Keywords
DRG, Diagnosis-Related Groups, ICD, reimbursement

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standard procedureOther

    Coding of cases follows the standard procedures established at the hospital

  • precodingOther

    Standard coding will be reviewed by dedicated physicians and corrected or extended if necessary.

    Coding will compared to the written OP report for consistency. Dedicated physician visits patients daily (in addition to routine visits). Dedicated physicians review discharge report and will make changes and additions. DRG coding will be adapted to results from visits and discharge report.

Study groups in NCT04726202
Study groupRoleWhat they receive
Control armstandard procedure of coding at hospital
Receives: Other: Standard procedure
Precoding armCoding of the standard procedure will be reviewed and corrected
Receives: Other: precoding

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. reimbursement per day at hospital

    total reimbursement per arm divided by the total stay of the patients in the arm in days

    Measured: 8 months

Secondary outcomes (5)
  1. Length of hospital stay

    length of hopital stay in full days including entry and discharge day

    Measured: 8 months

  2. Total reimbursement per case

    reimbursement in Swiss Francs per case

    Measured: 8 months

  3. case mix index per case

    Financial department will provide the cost weight/case mix index per case

    Measured: 8 months

  4. Severity of perioperative complications

    complications during hospitalisation will be graded according to the Clavian-Dindo scale. In case of multiple complications the highest grade will be taken.

    Measured: 8 months

  5. readmission rate

    Rate of case related readmissions

    Measured: 8 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jan 2021
  2. Study start1 Jun 2019
  3. Primary completion1 Jan 2020
  4. Study completion31 Jan 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
1,200 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04726202
Sponsor's protocol ID
Chir201902
Status last verified
Aug 2021
First submitted
22 Jan 2021
Last updated
4 Aug 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Fillit H, Geldmacher DS, Welter RT, Maslow K, Fraser M. Optimizing coding and reimbursement to improve management of Alzheimer's disease and related dementias. J Am Geriatr Soc. 2002 Nov;50(11):1871-8. doi: 10.1046/j.1532-5415.2002.50519.x.

    PubMed 12410910
  • Fetter RB, Freeman JL. Diagnosis related groups: product line management within hospitals. Acad Manage Rev. 1986 Jan;11(1):41-54.

    PubMed 10311457
  • Fetter RB. Hospital payment based on diagnosis-related groups. J Soc Health Syst. 1992;3(4):4-15.

    PubMed 1288673
  • Freeman JL, Fetter RB, Park H, Schneider KC, Lichtenstein JL, Hughes JS, Bauman WA, Duncan CC, Freeman DH Jr, Palmer GR. Diagnosis-related group refinement with diagnosis- and procedure-specific comorbidities and complications. Med Care. 1995 Aug;33(8):806-27. doi: 10.1097/00005650-199508000-00006.

    PubMed 7637403
  • Hughes JS, Lichtenstein J, Fetter RB. Procedure codes: potential modifiers of diagnosis-related groups. Health Care Financ Rev. 1990 Fall;12(1):39-46.

    PubMed 10113461
  • Geuss S, Jungmeister A, Baumgart A, Seelos R, Ockert S. [Prospective DRG coding : Improvement in cost-effectiveness and documentation quality of in-patient hospital care]. Chirurg. 2018 Feb;89(2):138-145. doi: 10.1007/s00104-017-0555-4. German.

    PubMed 29188352
  • Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13. doi: 10.1097/01.sla.0000133083.54934.ae.

    PubMed 15273542
  • Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009 Aug;250(2):187-96. doi: 10.1097/SLA.0b013e3181b13ca2.

    PubMed 19638912

Questions about this trial

What is this clinical trial studying?

An observational study of Diagnosis-Related Groups and Healthcare Common Procedure Coding System, run by Thomas Steffen at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

reimbursement per day at hospital (time frame: 8 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04726202, which also lists 8 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Aug 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in